Global Statistics

spot_img

Danielle Garcia

A proactive, determined and intra-entrepreneur, Garcia has more than 10 years of experience in the areas of medical and pharmaceutical communication, press relations, organizational communication and digital marketing. Garcia is also an experienced people manager and, with a focus on oncology and hematology, she provides targeted training and presentations (webinars) in all aspects of (bio-) pharmaceutical manufacturing.
Author's Latest

IASO Bio’s Anti-GPRC5D CAR T-Cell RD118 Shows Promising Results in Relapsed/Refractory Multiple Myeloma

IASO Biotherapeutics, a biopharmaceutical company focused on the discovery, development, production, and commercialization of novel cell therapies, today announced that the Blood published the...

Lupus Foundation Showcases Research at 2025 Annual Meeting of the American College of Rheumatology

The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research at the American College of Rheumatology...

Liposarcoma: Increasing Awareness, Earlier Diagnosis and Expanding Pool of Treatable Patients Drives Market

Liposarcoma market growth is driven by increasing awareness and earlier diagnosis, expanding the pool of treatable patients. Advances in molecular profiling and targeted therapies...

First-in-Human Phase I Trial of anti-CD20/BCMA Bispecific CAR-T Therapy in Patients with Refractory Autoimmune Diseases

AbelZeta Pharma, a global clinical-stage biopharmaceutical company focused on discovery and development of innovative and proprietary cell-based therapeutic products, today announced that clinical data...

First Follicular Lymphoma Patient Treated in CELESTIAL-301 Trial

Chimeric Antigen Receptor (CAR) T-cell therapies have revolutionized the treatment of B-cell Non-Hodgkin Lymphoma (NHL), demonstrating robust and durable responses even in heavily pretreated...

HaemaLogiX Presents Updates on Novel Therapeutic Targets

During the 22nd International Myeloma Society (IMS) Annual Meeting & Exposition, held 14 – 17 September 14 17 2025 in Toronto, Canada, HaemaLogiX, a...

Results of a First-in-Human Study Demonstrates Feasibility of In Vivo CAR T-Cell Therapy in Systemic Lupus Erythematosus

The first clinical data for an mRNA-lipid nanoparticle (mRNA-LNP)- based in vivo CAR T-cell candidate, HN2301*, developed by MagicRNA, were published in The New...

Gabriele Casirati, MD receives the 2025 ASH Peter Steelman Scholar Award

Deerfield Management and the Deerfield Foundation have awarded the 2025 recipient of the American Society of Hematology (ASH) Peter Steelman Scholar Award* to Gabriele...

Preliminary Clinical Data of Allogeneic CD19/CD20 CAR T-Cell Therapy Shows Promisse in Mantle Cell Lymphoma

During the 19th National Conference on Hematology of the Chinese Medical Association held in Beijing, China, held in September 2015, Professor Xiaoxi Zhou, MD,...

HaemaLogiX wins Most Promising CAR-T Pipeline in APAC

Australian biotech HaemaLogiX was awarded the Most Promising CAR-T Pipeline in APAC at the Asia Pacific CGT (Cell and Gene Therapy) Excellence Awards 2025,...

Kytopen and BlueWhale Bio Collaborate in Cell Therapy Manufacturing

Kytopen, a company providing continuous-flow cellular engineering technologies, and BlueWhale Bio, which focuses on accelerating the growth and adoption of cell-based therapies by transforming...

AbbVie to Acquire Capstan Therapeutics

AbbVie and Capstan Therapeutics, a clinical-stage biotechnology company, have signed a definitive agreement under which AbbVie will acquire Capstan, including its lead asset, CPTX2309,...

EHA 2025: Promising Long-Term Outcomes for C-CAR039, a Novel CD19/CD20 Bi-Specific CAR-T Therapy

During the European Hematology Association (EHA) Congress, which was held June 12 - 15, 2025, in Milan, Italy, scientists from AbelZeta Pharma, formerly known...

ASCO 2025: Transformative Data in 1L Metastatic Triple-Negative Breast Cancer, Updated Results in Multiple Myeloma and Early Data From Novel Investigational CAR T-Cell Therapy...

During the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 30 – June 3, and the 2025 European Hematology Association...

- A word from our sponsors -

spot_img

Follow us

HomeAuthorsPosts by Danielle Garcia

The Journal of CAR T-Cell Therapy is an international science & medicine-focused news publication designed to serve the needs of a diverse community, including academia, life sciences, pharma, clinical research, clinicians, and physicians. Along with global clinical and regulatory news, we also cover payor and policy-related news and updates.

© Copyright 2025, 2026 Sunvalley Communication, LLC and AAMEI®, American Association for Medical Education and Information - All Rights Reserved.

Quick Links

Must Read

Popular Articles